{"acquisitions":[],"changes":[],"country":"US","description":"Cell Directed Immunomodulation Therapy as a Bridge to Left Ventricular Device Implantation in Chronic Heart Failure Patients","domain":"innbio.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","industrySources":[],"investors":[],"lat":42.281372,"lng":-83.748462,"location":"Ann Arbor, Michigan","multiples":[],"name":"Innovative Biotherapies, Inc.","people":[],"revenues":[],"rounds":[{"amountQuarantined":false,"amountUsd":2827948,"connectionsAmong":[],"currency":"USD","date":"2024-01-01","investments":[],"investors":[],"leadInvestor":null,"leadInvestors":[],"people":[],"slug":"innbio-com-2024-01-01-grant","source":{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"innbio-com","sources":[{"fact":"round","publisher":"sbir","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"innbio.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://innbio.com"},{"fact":"description","publisher":"innbio.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://innbio.com"}],"stage":null,"stockCard":{"asOf":"2026-11-09","facts":[],"generatedAt":"2026-11-09","state":"insufficient-evidence","tldr":[]},"techStack":["Apache HTTP Server","jquery 1.3","apache"],"totalRaisedUsd":2827948,"traction":[],"updatedAt":"2026-05-02","valuations":[]}